查看購物車
  • English
  • Japanese
  • Korean
全球醫用塑膠市場：按類型、應用和地區分類－預測至2031年
市場調查報告書
商品編碼
2107269

全球醫用塑膠市場：按類型、應用和地區分類－預測至2031年

Medical Plastics Market by Type (Standard Plastics, Engineering Plastics, High-performance Plastics), Application (Medical Disposables, Medical Instruments & Devices, Prosthetics & Implants, Drug Delivery, Medical Packaging) - Global Forecast to 2031
出版日期: | 出版商: MarketsandMarkets | 英文 295 Pages | 訂單完成後即時交付

價格

全球醫用塑膠市場預計到 2026 年將達到 347.7 億美元，到 2031 年將達到 487.7 億美元，預測期內複合年成長率為 7.0%。

對先進醫療設備和一次性醫療產品日益成長的需求正在推動市場成長。對醫療用途的安全、輕盈、高效聚合物的需求不斷增加，以及人口老化導致慢性病盛行率上升，都創造了成長機會。

調查範圍
調查期 2023-2031
基準年 2025
預測期 2026-2031
計算單位 金額（100萬/10億美元） 數量（千噸）
部分 按類型、按應用、按地區
目標區域 北美洲、亞太地區、歐洲、中東和非洲、南美洲

此外，微創手術的日益普及，以及為降低感染率而採用一次性醫療設備，也推動了市場成長。

醫用塑膠市場 - IMG1

“預計2026年至2031年間，高性能塑膠領域將實現最高的複合年成長率。”

按類型分類，高性能塑膠預計將在預測期內成為醫療塑膠市場中成長最快的細分市場。這一成長歸功於其卓越的機械強度、耐化學性、優異的熱穩定性和生物相容性。 PEEK、PTFE 和 PPSU 等高科技材料是該細分市場的代表。此細分市場應用於高階醫療領域，即使在嚴苛的醫療環境中，也需要高可靠性和高性能。由於其輕量、尺寸穩定性好、耐磨損且可重複消毒，這些材料主要用於整形外科和脊椎植入、手術器械、導管組件、藥物輸送系統、牙科器械以及其他需要反覆消毒的工具。此外，其滲透性、耐腐蝕性和設計柔軟性使其能夠在實際應用中取代金屬材料。

“預計到 2031 年，醫用一次性用品領域將佔據醫用塑膠市場最大的佔有率。”

從應用領域來看，預計到2031年，醫療一次性用品市場將佔據最大的市場佔有率，這主要得益於其在醫院、門診診所、診斷檢查室和居家醫療領域的廣泛應用。包括注射器、手套、靜脈輸液組件、採血裝置、手術耗材、檢體容器和一次性呼吸用品在內的多種產品，都高度依賴醫用塑膠，以在經濟高效的生產水平下保持無菌狀態，並確保患者安全。手術數量的增加、感染控制措施的加強、疫苗接種和診斷項目的擴展，以及一次性塑膠製品的日益普及，都在推動對醫療一次性用品的需求。此外，嚴格的法規結構和對預防醫院感染的高度重視，也鞏固了該細分市場在市場中的主導地位。

“在預測期內，歐洲有望成為醫用塑膠的第二大市場。”

預計從2026年到2031年，歐洲將佔據全球第二大醫用塑膠市場佔有率，這主要得益於其先進的醫療設備製造業、完善的醫療基礎設施以及對醫用塑膠和病患安全的嚴格監管。該地區匯聚了許多領先的醫療設備、聚合物和其他醫療包裝產品製造商，推動了高性能醫用塑膠的創新發展。微創手術需求的成長、人口老化、慢性病的盛行率上升以及製藥和生物技術產業的擴張，都在推動該地區的市場發展。

本報告涵蓋的公司包括BASF（德國）、塞拉尼斯公司（美國）、沙烏地阿拉伯基礎工業公司（沙烏地阿拉伯）、科思創股份公司（德國）、賽恩斯克（比利時）、贏創工業集團（德國）、阿科瑪（法國）、路博潤（美國）、恩欣格（德國）和陶氏（美國）。

本研究對醫用塑膠市場的主要參與者進行了詳細的競爭分析，包括公司簡介、近期發展和主要市場策略。

調查範圍

本研究報告根據類型（標準塑膠、工程塑膠、高性能塑膠、矽膠及其他）和應用（一次性醫用產品、醫療器材及設備、假體及植入、藥物輸送、醫療包裝及其他應用）對醫用塑膠市場進行細分。該報告詳細分析了影響市場成長的促進因素、阻礙因素、挑戰和機遇，並對主要行業參與者進行了深入分析，包括其業務概況、產品組合以及與醫用塑膠市場相關的關鍵策略，例如併購、產品發布和業務擴張。此外，報告還對醫用塑膠市場生態系統中的新興企業進行了競爭分析。

購買本報告的理由

本報告為市場領導和新參與企業提供醫用塑膠市場整體及各細分市場最準確的銷售預測。它幫助相關人員了解競爭格局，獲得更深入的洞察以更好地定位自身業務，並制定合適的打入市場策略。此外，它還幫助相關人員了解市場趨勢，並獲取有關關鍵市場促進因素、阻礙因素、挑戰和機會的資訊。

本報告深入分析了以下幾點：

  • 對關鍵促進因素（對一次性醫療設備的需求不斷成長、全球老化和慢性病負擔日益加重，以及先進醫療設備和微創手術的日益普及）、阻礙因素（嚴格的法規和材料驗證要求，以及與塑膠廢棄物相關的環境問題）、機遇（生物基和永續的聚合物的永續性擴張，以及新興經濟體醫療保健基礎設施的複雜性）和醫療保健基礎設施的複雜性
  • 產品開發/創新：深入了解醫療塑膠市場的未來技術、研發活動以及產品/服務發布。
  • 市場發展：關於盈利市場的全面資訊（本報告分析了各個地區的醫用塑膠市場）
  • 市場多元化：全面介紹醫療塑膠市場的新產品和服務、未開發的地區、近期趨勢和投資情況。
  • 競爭分析：BASF（德國）、塞拉尼斯公司（美國）、沙烏地阿拉伯基礎工業公司（沙烏地阿拉伯）、科思創股份公司（德國）、賽恩斯克（比利時）、贏創工業集團（德國）、阿科瑪（法國）、路博潤（美國）、恩欣格（德國）和陶氏（美國）等主要公司的市場佔有率、成長策略和服務產品進行詳細評估。

目錄

第1章：引言

第2章執行摘要

第3章重要考察

第4章 市場概覽

  • 市場動態
    • 促進因素
    • 抑制因子
    • 機會
    • 任務
  • 未滿足的需求和未開發的領域
  • 相互關聯的市場與跨產業機遇
  • 一級/二級/三級公司的策略性舉措
  • 波特五力分析
  • 價值鏈分析
  • 生態系統
  • 價格分析
  • 總體經濟指標
  • 2025年美國關稅對醫用塑膠市場的影響。
  • 貿易分析
  • 影響客戶業務的趨勢/顛覆性因素
  • 投資和資金籌措場景
  • 案例研究分析
  • 重要會議和活動

第5章：技術進步、人工智慧的影響、專利、創新與未來應用

  • 技術分析
  • 技術/產品藍圖
  • 專利分析
  • 未來應用
  • 人工智慧/生成式人工智慧對醫用塑膠市場的影響

第6章：監理情勢與永續性舉措

  • 當地法規和合規性
  • 監理政策和永續性舉措的影響
  • 認證、標籤檢視和環境標準

第7章：顧客趨勢與購買行為

  • 決策流程
  • 主要相關人員和採購標準
  • 實施障礙和內部挑戰
  • 各個終端用戶產業尚未滿足的需求
  • 市場盈利

第8章：醫用塑膠市場（按類型分類）

  • 聚丙烯（PP）
  • 聚氯乙烯（PVC）
  • 聚乙烯（PE）
  • 聚苯乙烯（PS）
  • 聚甲基丙烯酸甲酯（PMMA）
  • 工程塑膠和高性能塑膠
  • 其他

第9章：醫用塑膠市場（依應用領域分類）

  • 醫用拋棄式
  • 醫療器材與設備
  • 義肢、矯正器具和植入
  • 藥物輸送
  • 醫療包裝
  • 其他

第10章：醫用塑膠市場（依地區分類）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 西班牙
    • 英國
    • 義大利
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 其他
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他

第11章 競爭格局

  • 概述
  • 主要公司的策略/優勢
  • 2021-2025年收入分析
  • 2025年市佔率分析
  • 產品對比
  • 企業估值矩陣：主要公司，2025 年
  • 公司估值矩陣：新創企業/中小企業，2025 年
  • 企業估值和財務指標
  • 競爭格局

第12章：公司簡介

  • 大公司
    • BASF
    • CELANESE CORPORATION
    • SABIC
    • COVESTRO AG
    • SYENSQO
    • EVONIK INDUSTRIES
    • ARKEMA
    • LUBRIZOL
    • ENSINGER
    • DOW
  • 其他公司
    • TRINSEO
    • BIOMERICS
    • ENVALIOR
    • EASTMAN CHEMICAL COMPANY
    • INVIBIO LTD.
    • LYONDELLBASELL INDUSTRIES HOLDINGS BV
    • MITSUBISHI CHEMICAL GROUP
    • AVIENT CORPORATION
    • ROCHLING SE & CO. KG
    • RTP COMPANY
    • SAINT-GOBAIN
    • TEKNI-PLEX, INC.
    • TEKNOR APEX COMPANY
    • WACKER CHEMIE AG
    • GEON PERFORMANCE SOLUTIONS LLC

第13章：調查方法

第14章附錄

Product Code: CH 3892

The global medical plastics market is expected to be valued at USD 34.77 billion in 2026 and USD 48.77 billion by 2031, registering a CAGR of 7.0% during the forecast period. Rising demand for advanced medical devices and single-use healthcare products is driving the market. The mounting demand for safe, lightweight, and efficient polymers for healthcare applications and the growing incidence of chronic diseases among an aging population create market growth opportunities.

Scope of the Report
Years Considered for the Study2023-2031
Base Year2025
Forecast Period2026-2031
Units ConsideredValue (USD Million/Billion) Volume (Kiloton)
SegmentsType and Application
Regions coveredNorth America, Asia Pacific, Europe, the Middle East & Africa, and South America

Furthermore, the increasing use of minimally invasive procedures, combined with the use of disposable medical devices to decrease infection rates, also adds to the momentum of the market.

Medical Plastics Market - IMG1

"High-performance plastics segment to record the highest CAGR from 2026 to 2031"

In terms of type, the high-performance plastics segment is anticipated to be the fastest-growing in the medical plastics market during the forecast period. The segmental growth is attributed to its remarkable mechanical strength, chemical resistance, excellent thermal stability, and biocompatibility. High-tech materials, including PEEK, PTFE, and PPSU, represent this segment. It is embraced in high-end medical applications looking for high reliability and performance under demanding medical conditions. Orthopedic and spinal implants, surgical instruments, catheter parts, drug delivery systems, dental devices, and tools used in repeated sterilization are among the key applications of these materials due to their low weight, dimensional stability, resistance to wear, and repeated sterilization ability. In addition, they can replace metals in the field while being radiolucent and offering corrosion resistance and design flexibility.

"Medical disposables segment to hold the largest share of the medical plastics market in 2031"

In terms of application, the medical disposables segment is projected to capture the largest market share in 2031, owing to the extensive usage in hospitals, ambulatory care facilities, diagnostic laboratories, and home healthcare. Various products, including syringes, gloves, IV components, blood collection devices, surgical disposables, specimen containers, and disposable respiratory products, heavily depend on medical-grade plastics to maintain sterility and ensure patient safety at a cost-effective production level. Increasing volumes of surgical procedures, rising measures taken for infection prevention, growing vaccination and diagnostic programs, and increasing popularity of disposable plastic products drive the demand for medical disposables. Moreover, the stringent regulatory framework and the emphasis on the prevention of hospital-acquired infections solidify the market leadership of the segment.

"Europe to be the second-largest region in the medical plastics market during the forecast period"

In terms of region, Europe is anticipated to hold the second-largest share of the medical plastic market between 2026 and 2031 due to the advanced medical device manufacturing industry, better healthcare infrastructure, and strict regulations governing medical plastic and patient safety. The region houses many prominent manufacturers of medical devices, polymers, and other packaging products for healthcare, hence stimulating innovations in high-performance medical plastics. Increased need for minimally invasive procedures, aging populations, growing prevalence of chronic diseases, and expansion of the pharmaceutical and biotech industry are driving the regional market.

Breakdown of Primary Interviews:

By Company Type: Tier 1: 40%, Tier 2: 30%, and Tier 3: 30%

By Designation: Directors: 30%, Managers: 20%, and Others: 50%

By Region: North America: 20%, Europe: 10%, Asia Pacific: 40%, South America: 10%, and Middle East & Africa: 20%

Notes: Others include sales, marketing, and product managers.

Tier 1: >USD 1 Billion; Tier 2: USD 500 million-1 Billion; and Tier 3: <USD 500 million

Companies Covered: BASF (Germany), Celanese Corporation (US), SABIC (Saudi Arabia), Covestro AG (Germany), Syensqo (Belgium), Evonik Industries (Germany), Arkema (France), Lubrizol (US), Ensinger (Germany), and Dow (US), among others, are covered in the report.

The study includes an in-depth competitive analysis of these key players in the medical plastics market, with their company profiles, recent developments, and key market strategies.

Research Coverage

This research report categorizes the medical plastics market based on type (standard plastics, engineering plastics, high-performance plastics, silicone, and other types) and application (medical disposables, medical instruments & devices, prosthetics & implants, drug delivery, medical packaging, and other applications). The report's scope covers detailed information regarding drivers, restraints, challenges, and opportunities influencing the market growth. A detailed analysis of the key industry players has been done to provide insights into their business overviews, products offered, and key strategies, such as mergers, acquisitions, product launches, and expansions, associated with the medical plastics market. This report covers a competitive analysis of upcoming startups in the medical plastics market ecosystem.

Reasons to Buy the Report

The report will offer the market leaders/new entrants with information on the closest approximations of the revenue numbers for the overall medical plastics market and the subsegments. This report will help stakeholders understand the competitive landscape, gain more insights into positioning their businesses better, and plan suitable go-to-market strategies. The report will also help stakeholders understand the pulse of the market and provide them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights into the following points:

  • Analysis of key drivers (Rising demand for single-use and disposable medical devices, Growing global aging population and chronic disease burden, Increasing adoption of advanced medical devices and minimally invasive procedures), restraints (Stringent regulatory and material validation requirements, Environmental concerns related to plastic waste), opportunities (Growing adoption of bio-based and sustainable medical plastics, Expanding healthcare infrastructure in emerging economies), and challenges (Issues in balancing sustainability requirements with stringent medical performance standards, Supply chain complexity for high-performance medical-grade polymers)
  • Product Development/Innovation: Detailed insights into upcoming technologies, research & development activities, and product & service launches in the medical plastics market
  • Market Development: Comprehensive information about profitable markets (the report analyzes the medical plastics market across varied regions)
  • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the medical plastics market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players such as BASF (Germany), Celanese Corporation (US), SABIC (Saudi Arabia), Covestro AG (Germany), Syensqo (Belgium), Evonik Industries (Germany), Arkema (France), Lubrizol (US), Ensinger (Germany), and Dow (US), among others

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
    • 1.3.2 INCLUSIONS AND EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
    • 1.3.5 UNITS CONSIDERED
  • 1.4 STAKEHOLDERS
  • 1.5 SUMMARY OF CHANGES

2 EXECUTIVE SUMMARY

  • 2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS
  • 2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS
  • 2.3 DISRUPTIVE TRENDS SHAPING THE MARKET
  • 2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
  • 2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

  • 3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN MEDICAL PLASTICS MARKET
  • 3.2 ASIA PACIFIC: MEDICAL PLASTICS MARKET, BY APPLICATION AND COUNTRY
  • 3.3 MEDICAL PLASTICS MARKET, BY TYPE
  • 3.4 MEDICAL PLASTICS MARKET, BY COUNTRY

4 MARKET OVERVIEW

  • 4.1 INTRODUCTION
  • 4.2 MARKET DYNAMICS
    • 4.2.1 DRIVERS
      • 4.2.1.1 Rising demand for single-use and disposable medical devices
      • 4.2.1.2 Growing global aging population and rising chronic disease burden
      • 4.2.1.3 Increasing adoption of advanced medical devices and minimally invasive procedures
    • 4.2.2 RESTRAINTS
      • 4.2.2.1 Stringent regulatory and material validation requirements
      • 4.2.2.2 Environmental concerns related to plastic waste
    • 4.2.3 OPPORTUNITIES
      • 4.2.3.1 Growing adoption of bio-based and sustainable medical plastics
      • 4.2.3.2 Expanding healthcare infrastructure in emerging economies
    • 4.2.4 CHALLENGES
      • 4.2.4.1 Balancing sustainability requirements with stringent medical performance standards
      • 4.2.4.2 Supply chain complexity for high-performance medical-grade polymers
  • 4.3 UNMET NEEDS AND WHITE SPACES
    • 4.3.1 UNMET NEEDS IN MEDICAL PLASTICS MARKET
    • 4.3.2 WHITE SPACE OPPORTUNITIES
  • 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
  • 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
    • 4.5.1 KEY MOVES AND STRATEGIC FOCUS
  • 4.6 PORTER'S FIVE FORCES ANALYSIS
    • 4.6.1 BARGAINING POWER OF SUPPLIERS
    • 4.6.2 BARGAINING POWER OF BUYERS
    • 4.6.3 THREAT OF SUBSTITUTES
    • 4.6.4 THREAT OF NEW ENTRANTS
    • 4.6.5 INTENSITY OF COMPETITIVE RIVALRY
  • 4.7 VALUE CHAIN ANALYSIS
    • 4.7.1 RAW MATERIAL SUPPLIERS
    • 4.7.2 DISTRIBUTORS
    • 4.7.3 MANUFACTURERS
    • 4.7.4 END CONSUMERS
  • 4.8 ECOSYSTEM
  • 4.9 PRICING ANALYSIS
    • 4.9.1 AVERAGE SELLING PRICE TREND, BY REGION
  • 4.10 MACROECONOMIC INDICATORS
    • 4.10.1 GLOBAL GDP TRENDS
    • 4.10.2 HEALTHCARE INDUSTRY TRENDS
  • 4.11 IMPACT OF 2025 US TARIFFS ON MEDICAL PLASTICS MARKET
    • 4.11.1 INTRODUCTION
    • 4.11.2 KEY TARIFF RATES
    • 4.11.3 PRICE IMPACT ANALYSIS
    • 4.11.4 IMPACT ON COUNTRIES/REGIONS
      • 4.11.4.1 US
      • 4.11.4.2 Europe
      • 4.11.4.3 Asia Pacific
    • 4.11.5 IMPACT ON END-USE INDUSTRIES
  • 4.12 TRADE ANALYSIS
    • 4.12.1 IMPORT SCENARIO (HS CODE 3926)
    • 4.12.2 EXPORT SCENARIO (HS CODE 3926)
  • 4.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 4.14 INVESTMENT AND FUNDING SCENARIO
  • 4.15 CASE STUDY ANALYSIS
    • 4.15.1 COVESTRO AG INTRODUCES CIRCULAR MEDICAL-GRADE POLYCARBONATE FOR HEALTHCARE APPLICATIONS
    • 4.15.2 CELANESE CORPORATION EXPANDS GUR UHMW-PE PORTFOLIO FOR MEDICAL APPLICATIONS
    • 4.15.3 EVONIK INDUSTRIES ADVANCES IMPLANTABLE BIOMATERIALS FOR MEDICAL DEVICES
  • 4.16 KEY CONFERENCES & EVENTS

5 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

  • 5.1 TECHNOLOGY ANALYSIS
    • 5.1.1 KEY TECHNOLOGIES
      • 5.1.1.1 Bio-based and bio-attributed medical-grade polymers
      • 5.1.1.2 High-performance polymers for implantable and minimally invasive devices
      • 5.1.1.3 Medical-grade additive manufacturing (3D printing) of polymers
    • 5.1.2 COMPLEMENTARY TECHNOLOGIES
      • 5.1.2.1 AI-powered quality inspection and smart manufacturing systems
      • 5.1.2.2 Digital twin technology for manufacturing process optimization
  • 5.2 TECHNOLOGY/PRODUCT ROADMAP
    • 5.2.1 SHORT TERM (2025-2027) | MATERIAL INNOVATION & REGULATORY FOUNDATION
    • 5.2.2 MID-TERM (2027-2030) | SMART MATERIALS & DIGITAL MANUFACTURING
    • 5.2.3 LONG TERM (2030-2030+) | SUSTAINABLE HIGH-PERFORMANCE MATERIALS & AUTONOMOUS MANUFACTURING
  • 5.3 PATENT ANALYSIS
    • 5.3.1 LEGAL STATUS OF PATENTS
    • 5.3.2 JURISDICTION ANALYSIS
  • 5.4 FUTURE APPLICATIONS
    • 5.4.1 ADVANCED SINGLE-USE MEDICAL DEVICES & INFECTION PREVENTION
    • 5.4.2 ADVANCED DRUG DELIVERY & COMBINATION MEDICAL DEVICES
    • 5.4.3 BIOPHARMACEUTICAL MANUFACTURING & ADVANCED THERAPIES
    • 5.4.4 SMART DIAGNOSTICS, WEARABLE HEALTHCARE & HOME MEDICAL DEVICES
    • 5.4.5 ROBOTIC SURGERY, MINIMALLY INVASIVE DEVICES & HIGH-PERFORMANCE MEDICAL COMPONENTS
  • 5.5 IMPACT OF AI/GEN AI ON MEDICAL PLASTICS MARKET
    • 5.5.1 TOP USE CASES AND MARKET POTENTIAL OF MEDICAL PLASTICS
    • 5.5.2 BEST PRACTICES IN MEDICAL PLASTICS PROCESSING
    • 5.5.3 CASE STUDIES OF AI IMPLEMENTATION IN MEDICAL PLASTICS MARKET
    • 5.5.4 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
    • 5.5.5 CLIENTS' READINESS TO ADOPT GENERATIVE AI IN MEDICAL PLASTICS MARKET

6 REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES

  • 6.1 REGIONAL REGULATIONS AND COMPLIANCE
    • 6.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 6.1.2 INDUSTRY STANDARDS
  • 6.2 IMPACT OF REGULATORY POLICIES AND SUSTAINABILITY INITIATIVES
  • 6.3 CERTIFICATIONS, LABELING, AND ECO-STANDARDS

7 CUSTOMER LANDSCAPE & BUYER BEHAVIOR

  • 7.1 INTRODUCTION
  • 7.2 DECISION-MAKING PROCESS
  • 7.3 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 7.3.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 7.3.2 BUYING CRITERIA
  • 7.4 ADOPTION BARRIERS & INTERNAL CHALLENGES
  • 7.5 UNMET NEEDS IN VARIOUS END-USE INDUSTRIES
  • 7.6 MARKET PROFITABILITY
    • 7.6.1 REVENUE POTENTIAL
    • 7.6.2 COST DYNAMICS
    • 7.6.3 MARGIN OPPORTUNITIES IN KEY END-USE INDUSTRIES

8 MEDICAL PLASTICS MARKET, BY TYPE

  • 8.1 INTRODUCTION
  • 8.2 POLYPROPYLENE (PP)
    • 8.2.1 HIGH FATIGUE RESISTANCE AND STERILIZATION STABILITY SUPPORTING REUSABLE AND DISPOSABLE DEVICES
  • 8.3 POLYVINYL CHLORIDE (PVC)
    • 8.3.1 EXCELLENT FLEXIBILITY, STERILIZATION COMPATIBILITY, AND COST EFFICIENCY TO SUPPORT HIGH-VOLUME MEDICAL APPLICATIONS
  • 8.4 POLYETHYLENE (PE)
    • 8.4.1 OUTSTANDING CHEMICAL RESISTANCE AND BIOCOMPATIBILITY DRIVING DISPOSABLE HEALTHCARE PRODUCTS
  • 8.5 POLYSTYRENE (PS)
    • 8.5.1 SUPERIOR CLARITY AND DIMENSIONAL PRECISION ENABLING DIAGNOSTIC AND LABORATORY APPLICATIONS
  • 8.6 POLYMETHYL METHACRYLATE (PMMA)
    • 8.6.1 HIGH OPTICAL TRANSPARENCY AND WEATHER RESISTANCE ADVANCING SPECIALIZED MEDICAL DEVICES
  • 8.7 ENGINEERING AND HIGH PERFORMANCE PLASTICS
    • 8.7.1 POLYETHER ETHER KETONE (PEEK)
      • 8.7.1.1 Superior mechanical performance and biocompatibility accelerating implant innovation
    • 8.7.2 POLYAMIDE (PA)
      • 8.7.2.1 Excellent mechanical strength and wear resistance supporting precision medical components
    • 8.7.3 POLYPHENYLSULFONE (PPSU)
      • 8.7.3.1 Excellent sterilization durability and impact resistance supporting reusable medical devices
    • 8.7.4 POLYSULFONE (PSU)
      • 8.7.4.1 High thermal stability and hydrolytic resistance driving adoption in reusable medical devices
    • 8.7.5 POLYCARBONATE (PC)
      • 8.7.5.1 Exceptional transparency and impact resistance supporting advanced healthcare devices
    • 8.7.6 ACRYLONITRILE BUTADIENE STYRENE (ABS)
      • 8.7.6.1 High impact strength and dimensional stability enabling durable medical equipment
    • 8.7.7 OTHER ENGINEERING AND HIGH-PERFORMANCE PLASTICS
  • 8.8 OTHER TYPES

9 MEDICAL PLASTICS MARKET, BY APPLICATION

  • 9.1 INTRODUCTION
  • 9.2 MEDICAL DISPOSABLES
    • 9.2.1 MEDICAL BAGS
      • 9.2.1.1 Reliable fluid containment and sterility driving demand in healthcare
    • 9.2.2 CATHETERS
      • 9.2.2.1 Precision polymer technologies enabling minimally invasive therapies
    • 9.2.3 SYRINGES
      • 9.2.3.1 High-volume disposable devices supporting safe drug administration
    • 9.2.4 OTHER DISPOSABLES
  • 9.3 MEDICAL INSTRUMENTS & DEVICES
    • 9.3.1 SURGICAL INSTRUMENTS
      • 9.3.1.1 Lightweight engineering polymers improving surgical precision
    • 9.3.2 DIAGNOSTIC DEVICES
      • 9.3.2.1 Precision plastics enabling accurate diagnostic performance
    • 9.3.3 DENTAL INSTRUMENTS
      • 9.3.3.1 Durable biocompatible polymers advancing dental treatments
  • 9.4 PROSTHETICS & IMPLANTS
    • 9.4.1 LIMB PROSTHETICS
      • 9.4.1.1 Lightweight high-strength polymers enhancing patient mobility
    • 9.4.2 IMPLANTS
      • 9.4.2.1 Advanced biomaterials improving long-term clinical performance
  • 9.5 DRUG DELIVERY
  • 9.6 MEDICAL PACKAGING
  • 9.7 OTHER APPLICATIONS

10 MEDICAL PLASTICS MARKET, BY REGION

  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    • 10.2.1 US
      • 10.2.1.1 FDA regulatory excellence, robust healthcare spending, and advanced medical device manufacturing to drive market
    • 10.2.2 CANADA
      • 10.2.2.1 Universal healthcare investments, regulatory modernization, and expanding home healthcare services to accelerate growth
    • 10.2.3 MEXICO
      • 10.2.3.1 Nearshoring investments, export-oriented medical device manufacturing, and regulatory reforms propelling demand
  • 10.3 EUROPE
    • 10.3.1 GERMANY
      • 10.3.1.1 Advanced medical device manufacturing, healthcare reforms, and aging population to fuel demand
    • 10.3.2 FRANCE
      • 10.3.2.1 Biopharmaceutical innovation, government healthcare investments, and France 2030 Strategy to strengthen market
    • 10.3.3 SPAIN
      • 10.3.3.1 Strong economic growth, healthcare digitalization, and medical device investments accelerating market growth
    • 10.3.4 UK
      • 10.3.4.1 NHS investment, regulatory modernization, and life sciences innovation driving growth
    • 10.3.5 ITALY
      • 10.3.5.1 Mirandola biomedical cluster, healthcare modernization, and medical device manufacturing strength supporting market
    • 10.3.6 REST OF EUROPE
  • 10.4 ASIA PACIFIC
    • 10.4.1 CHINA
      • 10.4.1.1 Manufacturing scale, regulatory modernization, and healthcare investments driving market
    • 10.4.2 JAPAN
      • 10.4.2.1 Aging demographics, rising healthcare expenditure, and stringent regulatory standards to support market growth
    • 10.4.3 INDIA
      • 10.4.3.1 Production-linked incentives, healthcare infrastructure expansion, and rising domestic manufacturing to propel market
    • 10.4.4 SOUTH KOREA
      • 10.4.4.1 Government MedTech investments, advanced manufacturing, and digital healthcare expansion driving market
    • 10.4.5 REST OF ASIA PACIFIC
  • 10.5 MIDDLE EAST & AFRICA
    • 10.5.1 GCC COUNTRIES
      • 10.5.1.1 Healthcare infrastructure expansion, rising chronic disease burden, and medical technology investments to fuel demand
      • 10.5.1.2 Saudi Arabia
        • 10.5.1.2.1 Vision 2030 healthcare transformation, medical infrastructure investments, and regulatory modernization to support market growth
      • 10.5.1.3 UAE
        • 10.5.1.3.1 Healthcare hub development, regulatory transformation, and medical tourism drive market
      • 10.5.1.4 Rest of GCC
    • 10.5.2 SOUTH AFRICA
      • 10.5.2.1 National health insurance reform, expanding healthcare access, and rising chronic disease burden to support market
    • 10.5.3 REST OF MIDDLE EAST & AFRICA
  • 10.6 SOUTH AMERICA
    • 10.6.1 BRAZIL
      • 10.6.1.1 Universal healthcare expansion, healthcare infrastructure investments, and regulatory modernization to drive market
    • 10.6.2 ARGENTINA
      • 10.6.2.1 Macroeconomic stabilization, regulatory modernization, and rising healthcare demand to accelerate market
    • 10.6.3 REST OF SOUTH AMERICA

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 KEY PLAYERS' STRATEGIES/RIGHT TO WIN
  • 11.3 REVENUE ANALYSIS, 2021-2025
  • 11.4 MARKET SHARE ANALYSIS, 2025
  • 11.5 PRODUCT COMPARISON
  • 11.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
    • 11.6.1 STARS
    • 11.6.2 EMERGING LEADERS
    • 11.6.3 PERVASIVE PLAYERS
    • 11.6.4 PARTICIPANTS
    • 11.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
      • 11.6.5.1 Company footprint
      • 11.6.5.2 Region footprint
      • 11.6.5.3 Type footprint
      • 11.6.5.4 Application footprint
  • 11.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
    • 11.7.1 PROGRESSIVE COMPANIES
    • 11.7.2 RESPONSIVE COMPANIES
    • 11.7.3 DYNAMIC COMPANIES
    • 11.7.4 STARTING BLOCKS
    • 11.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
      • 11.7.5.1 Detailed list of key startups/SMEs
      • 11.7.5.2 Competitive benchmarking of key startups/SMEs
  • 11.8 COMPANY VALUATION & FINANCIAL METRICS
    • 11.8.1 FINANCIAL METRICS
    • 11.8.2 COMPANY VALUATION
    • 11.8.3 ENTERPRISE VALUATION
  • 11.9 COMPETITIVE SCENARIO
    • 11.9.1 PRODUCT LAUNCHES
    • 11.9.2 DEALS
    • 11.9.3 EXPANSIONS

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
    • 12.1.1 BASF
      • 12.1.1.1 Business overview
      • 12.1.1.2 Products/Solutions/Services offered
        • 12.1.1.2.1 Recent developments
        • 12.1.1.2.2 Expansions
      • 12.1.1.3 MnM view
        • 12.1.1.3.1 Right to win
        • 12.1.1.3.2 Strategic choices
        • 12.1.1.3.3 Weaknesses and competitive threats
    • 12.1.2 CELANESE CORPORATION
      • 12.1.2.1 Business overview
      • 12.1.2.2 Products/Solutions/Services offered
      • 12.1.2.3 Recent developments
        • 12.1.2.3.1 Deals
      • 12.1.2.4 MnM view
        • 12.1.2.4.1 Right to win
        • 12.1.2.4.2 Strategic choices
        • 12.1.2.4.3 Weaknesses and competitive threats
    • 12.1.3 SABIC
      • 12.1.3.1 Business overview
      • 12.1.3.2 Products/Solutions/Services offered
      • 12.1.3.3 Recent developments
        • 12.1.3.3.1 Product launches
        • 12.1.3.3.2 Deals
      • 12.1.3.4 MnM view
        • 12.1.3.4.1 Right to win
        • 12.1.3.4.2 Strategic choices
        • 12.1.3.4.3 Weaknesses and competitive threats
    • 12.1.4 COVESTRO AG
      • 12.1.4.1 Business overview
      • 12.1.4.2 Products/Solutions/Services offered
      • 12.1.4.3 Recent developments
        • 12.1.4.3.1 Product launches
      • 12.1.4.4 MnM view
        • 12.1.4.4.1 Right to win
        • 12.1.4.4.2 Strategic choices
        • 12.1.4.4.3 Weaknesses and competitive threats
    • 12.1.5 SYENSQO
      • 12.1.5.1 Business overview
      • 12.1.5.2 Products/Solutions/Services offered
      • 12.1.5.3 Recent developments
        • 12.1.5.3.1 Product launches
        • 12.1.5.3.2 Deals
      • 12.1.5.4 MnM view
        • 12.1.5.4.1 Right to win
        • 12.1.5.4.2 Strategic choices
        • 12.1.5.4.3 Weaknesses and competitive threats
    • 12.1.6 EVONIK INDUSTRIES
      • 12.1.6.1 Business overview
      • 12.1.6.2 Products/Solutions/Services offered
      • 12.1.6.3 Recent developments
        • 12.1.6.3.1 Product launches
        • 12.1.6.3.2 Expansions
      • 12.1.6.4 MnM view
    • 12.1.7 ARKEMA
      • 12.1.7.1 Business overview
      • 12.1.7.2 Products/Solutions/Services offered
      • 12.1.7.3 Recent developments
        • 12.1.7.3.1 Product launches
        • 12.1.7.3.2 Deals
      • 12.1.7.4 MnM view
    • 12.1.8 LUBRIZOL
      • 12.1.8.1 Business overview
      • 12.1.8.2 Products/Solutions/Services offered
      • 12.1.8.3 Recent developments
        • 12.1.8.3.1 Product launches
        • 12.1.8.3.2 Deals
        • 12.1.8.3.3 Expansions
      • 12.1.8.4 MnM view
    • 12.1.9 ENSINGER
      • 12.1.9.1 Business overview
      • 12.1.9.2 Products/Solutions/Services offered
      • 12.1.9.3 MnM view
    • 12.1.10 DOW
      • 12.1.10.1 Business overview
      • 12.1.10.2 Products/Solutions/Services offered
      • 12.1.10.3 Recent developments
        • 12.1.10.3.1 Deals
      • 12.1.10.4 MnM view
  • 12.2 OTHER PLAYERS
    • 12.2.1 TRINSEO
    • 12.2.2 BIOMERICS
    • 12.2.3 ENVALIOR
    • 12.2.4 EASTMAN CHEMICAL COMPANY
    • 12.2.5 INVIBIO LTD.
    • 12.2.6 LYONDELLBASELL INDUSTRIES HOLDINGS B.V.
    • 12.2.7 MITSUBISHI CHEMICAL GROUP
    • 12.2.8 AVIENT CORPORATION
    • 12.2.9 ROCHLING SE & CO. KG
    • 12.2.10 RTP COMPANY
    • 12.2.11 SAINT-GOBAIN
    • 12.2.12 TEKNI-PLEX, INC.
    • 12.2.13 TEKNOR APEX COMPANY
    • 12.2.14 WACKER CHEMIE AG
    • 12.2.15 GEON PERFORMANCE SOLUTIONS LLC

13 RESEARCH METHODOLOGY

  • 13.1 RESEARCH DATA
    • 13.1.1 SECONDARY DATA
      • 13.1.1.1 Key data from secondary sources
    • 13.1.2 PRIMARY DATA
      • 13.1.2.1 Key data from primary sources
      • 13.1.2.2 Key industry insights
  • 13.2 MARKET SIZE ESTIMATION
  • 13.3 BASE NUMBER CALCULATION
  • 13.4 MARKET FORECAST APPROACH
  • 13.5 DATA TRIANGULATION
  • 13.6 FACTOR ANALYSIS
  • 13.7 RESEARCH ASSUMPTIONS
  • 13.8 RESEARCH LIMITATIONS AND RISK ASSESSMENT

14 APPENDIX

  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3 CUSTOMIZATION OPTIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 CAPITAL HEALTHCARE EXPENDITURE, 2020-2023 (USD MILLION)
  • TABLE 2 HEALTHCARE SPENDING, 2023 (USD MILLION)
  • TABLE 3 MEDICAL PLASTICS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 4 MEDICAL PLASTICS MARKET: ROLES OF COMPANIES IN ECOSYSTEM
  • TABLE 5 GDP TRENDS AND FORECAST OF MAJOR ECONOMIES, 2023-2030 (USD BILLION, CURRENT PRICES)
  • TABLE 6 U.S. NATIONAL HEALTH EXPENDITURE (NHE) TRENDS, 2022-2033
  • TABLE 7 US-ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 8 IMPORT SCENARIO FOR HS CODE 3926-COMPLIANT PRODUCTS, BY COUNTRY, 2021-2025 (USD MILLION)
  • TABLE 9 EXPORT SCENARIO FOR HS CODE 3926-COMPLIANT PRODUCTS, BY COUNTRY, 2021-2025 (USD MILLION)
  • TABLE 10 MEDICAL PLASTICS MARKET: CONFERENCES & EVENTS, 2026-2027
  • TABLE 11 TOP USE CASES AND MARKET POTENTIAL
  • TABLE 12 BEST PRACTICES: NOTABLE INDUSTRY PRACTICES BY LEADING COMPANIES
  • TABLE 13 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
  • TABLE 14 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, INDUSTRY ASSOCIATIONS, AND OTHER ORGANIZATIONS
  • TABLE 15 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, INDUSTRY ASSOCIATIONS, AND OTHER ORGANIZATIONS
  • TABLE 16 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, INDUSTRY ASSOCIATIONS, AND OTHER ORGANIZATIONS
  • TABLE 17 GLOBAL STANDARDS IN MEDICAL PLASTICS MARKET
  • TABLE 18 CERTIFICATIONS, LABELING, AND ECO-STANDARDS IN MEDICAL PLASTICS MARKET
  • TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY APPLICATIONS (%)
  • TABLE 20 KEY BUYING CRITERIA FOR KEY APPLICATIONS
  • TABLE 21 MEDICAL PLASTICS MARKET: UNMET NEEDS IN KEY END-USE INDUSTRIES
  • TABLE 22 MEDICAL PLASTICS MARKET, BY TYPE, 2023-2025 (USD MILLION)
  • TABLE 23 MEDICAL PLASTICS MARKET, BY TYPE, 2026-2031 (USD MILLION)
  • TABLE 24 MEDICAL PLASTICS MARKET, BY TYPE, 2023-2025 (KILOTON)
  • TABLE 25 MEDICAL PLASTICS MARKET, BY TYPE, 2026-2031 (KILOTON)
  • TABLE 26 MEDICAL PLASTICS MARKET, BY APPLICATION, 2023-2025 (USD MILLION)
  • TABLE 27 MEDICAL PLASTICS MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 28 MEDICAL PLASTICS MARKET, BY APPLICATION, 2023-2025 (KILOTON)
  • TABLE 29 MEDICAL PLASTICS MARKET, BY APPLICATION, 2026-2031 (KILOTON)
  • TABLE 30 MEDICAL PLASTICS MARKET, BY REGION, 2023-2025 (USD MILLION)
  • TABLE 31 MEDICAL PLASTICS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 32 MEDICAL PLASTICS MARKET, BY REGION, 2023-2025 (KILOTON)
  • TABLE 33 MEDICAL PLASTICS MARKET, BY REGION, 2026-2031 (KILOTON)
  • TABLE 34 NORTH AMERICA: MEDICAL PLASTICS MARKET, BY COUNTRY, 2023-2025 (USD MILLION)
  • TABLE 35 NORTH AMERICA: MEDICAL PLASTICS MARKET, BY COUNTRY, 2026-2031 (USD MILLION)
  • TABLE 36 NORTH AMERICA: MEDICAL PLASTICS MARKET, BY COUNTRY, 2023-2025 (KILOTON)
  • TABLE 37 NORTH AMERICA: MEDICAL PLASTICS MARKET, BY COUNTRY, 2026-2031 (KILOTON)
  • TABLE 38 NORTH AMERICA: MEDICAL PLASTICS MARKET, BY TYPE, 2023-2025 (USD MILLION)
  • TABLE 39 NORTH AMERICA: MEDICAL PLASTICS MARKET, BY TYPE, 2026-2031 (USD MILLION)
  • TABLE 40 NORTH AMERICA: MEDICAL PLASTICS MARKET, BY TYPE, 2023-2025 (KILOTON)
  • TABLE 41 NORTH AMERICA: MEDICAL PLASTICS MARKET, BY TYPE, 2026-2031 (KILOTON)
  • TABLE 42 NORTH AMERICA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023-2025 (USD MILLION)
  • TABLE 43 NORTH AMERICA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 44 NORTH AMERICA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023-2025 (KILOTON)
  • TABLE 45 NORTH AMERICA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026-2031 (KILOTON)
  • TABLE 46 US: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023-2025 (USD MILLION)
  • TABLE 47 US: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 48 US: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023-2025 (KILOTON)
  • TABLE 49 US: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026-2031 (KILOTON)
  • TABLE 50 CANADA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023-2025 (USD MILLION)
  • TABLE 51 CANADA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 52 CANADA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023-2025 (KILOTON)
  • TABLE 53 CANADA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026-2031 (KILOTON)
  • TABLE 54 MEXICO: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023-2025 (USD MILLION)
  • TABLE 55 MEXICO: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 56 MEXICO: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023-2025 (KILOTON)
  • TABLE 57 MEXICO: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026-2031 (KILOTON)
  • TABLE 58 EUROPE: MEDICAL PLASTICS MARKET, BY COUNTRY, 2023-2025 (USD MILLION)
  • TABLE 59 EUROPE: MEDICAL PLASTICS MARKET, BY COUNTRY, 2026-2031 (USD MILLION)
  • TABLE 60 EUROPE: MEDICAL PLASTICS MARKET, BY COUNTRY, 2023-2025 (KILOTON)
  • TABLE 61 EUROPE: MEDICAL PLASTICS MARKET, BY COUNTRY, 2026-2031 (KILOTON)
  • TABLE 62 EUROPE: MEDICAL PLASTICS MARKET, BY TYPE, 2023-2025 (USD MILLION)
  • TABLE 63 EUROPE: MEDICAL PLASTICS MARKET, BY TYPE, 2026-2031 (USD MILLION)
  • TABLE 64 EUROPE: MEDICAL PLASTICS MARKET, BY TYPE, 2023-2025 (KILOTON)
  • TABLE 65 EUROPE: MEDICAL PLASTICS MARKET, BY TYPE, 2026-2031 (KILOTON)
  • TABLE 66 EUROPE: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023-2025 (USD MILLION)
  • TABLE 67 EUROPE: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 68 EUROPE: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023-2025 (KILOTON)
  • TABLE 69 EUROPE: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026-2031 (KILOTON)
  • TABLE 70 GERMANY: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023-2025 (USD MILLION)
  • TABLE 71 GERMANY: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 72 GERMANY: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023-2025 (KILOTON)
  • TABLE 73 GERMANY: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026-2031 (KILOTON)
  • TABLE 74 FRANCE: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023-2025 (USD MILLION)
  • TABLE 75 FRANCE: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 76 FRANCE: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023-2025 (KILOTON)
  • TABLE 77 FRANCE: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026-2031 (KILOTON)
  • TABLE 78 SPAIN: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023-2025 (USD MILLION)
  • TABLE 79 SPAIN: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 80 SPAIN: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023-2025 (KILOTON)
  • TABLE 81 SPAIN: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026-2031 (KILOTON)
  • TABLE 82 UK: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023-2025 (USD MILLION)
  • TABLE 83 UK: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 84 UK: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023-2025 (KILOTON)
  • TABLE 85 UK: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026-2031 (KILOTON)
  • TABLE 86 ITALY: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023-2025 (USD MILLION)
  • TABLE 87 ITALY: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 88 ITALY: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023-2025 (KILOTON)
  • TABLE 89 ITALY: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026-2031 (KILOTON)
  • TABLE 90 REST OF EUROPE: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023-2025 (USD MILLION)
  • TABLE 91 REST OF EUROPE: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 92 REST OF EUROPE: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023-2025 (KILOTON)
  • TABLE 93 REST OF EUROPE: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026-2031 (KILOTON)
  • TABLE 94 ASIA PACIFIC: MEDICAL PLASTICS MARKET, BY COUNTRY, 2023-2025 (USD MILLION)
  • TABLE 95 ASIA PACIFIC: MEDICAL PLASTICS MARKET, BY COUNTRY, 2026-2031 (USD MILLION)
  • TABLE 96 ASIA PACIFIC: MEDICAL PLASTICS MARKET, BY COUNTRY, 2023-2025 (KILOTON)
  • TABLE 97 ASIA PACIFIC: MEDICAL PLASTICS MARKET, BY COUNTRY, 2026-2031 (KILOTON)
  • TABLE 98 ASIA PACIFIC: MEDICAL PLASTICS MARKET, BY TYPE, 2023-2025 (USD MILLION)
  • TABLE 99 ASIA PACIFIC: MEDICAL PLASTICS MARKET, BY TYPE, 2026-2031 (USD MILLION)
  • TABLE 100 ASIA PACIFIC: MEDICAL PLASTICS MARKET, BY TYPE, 2023-2025 (KILOTON)
  • TABLE 101 ASIA PACIFIC: MEDICAL PLASTICS MARKET, BY TYPE, 2026-2031 (KILOTON)
  • TABLE 102 ASIA PACIFIC: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023-2025 (USD MILLION)
  • TABLE 103 ASIA PACIFIC: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 104 ASIA PACIFIC: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023-2025 (KILOTON)
  • TABLE 105 ASIA PACIFIC: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026-2031 (KILOTON)
  • TABLE 106 CHINA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023-2025 (USD MILLION)
  • TABLE 107 CHINA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 108 CHINA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023-2025 (KILOTON)
  • TABLE 109 CHINA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026-2031 (KILOTON)
  • TABLE 110 JAPAN: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023-2025 (USD MILLION)
  • TABLE 111 JAPAN: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 112 JAPAN: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023-2025 (KILOTON)
  • TABLE 113 JAPAN: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026-2031 (KILOTON)
  • TABLE 114 INDIA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023-2025 (USD MILLION)
  • TABLE 115 INDIA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 116 INDIA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023-2025 (KILOTON)
  • TABLE 117 INDIA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026-2031 (KILOTON)
  • TABLE 118 SOUTH KOREA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023-2025 (USD MILLION)
  • TABLE 119 SOUTH KOREA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 120 SOUTH KOREA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023-2025 (KILOTON)
  • TABLE 121 SOUTH KOREA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026-2031 (KILOTON)
  • TABLE 122 REST OF ASIA PACIFIC: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023-2025 (USD MILLION)
  • TABLE 123 REST OF ASIA PACIFIC: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 124 REST OF ASIA PACIFIC: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023-2025 (KILOTON)
  • TABLE 125 REST OF ASIA PACIFIC: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026-2031 (KILOTON)
  • TABLE 126 MIDDLE EAST & AFRICA: MEDICAL PLASTICS MARKET, BY COUNTRY, 2023-2025 (USD MILLION)
  • TABLE 127 MIDDLE EAST & AFRICA: MEDICAL PLASTICS MARKET, BY COUNTRY, 2026-2031 (USD MILLION)
  • TABLE 128 MIDDLE EAST & AFRICA: MEDICAL PLASTICS MARKET, BY COUNTRY, 2023-2025 (KILOTON)
  • TABLE 129 MIDDLE EAST & AFRICA: MEDICAL PLASTICS MARKET, BY COUNTRY, 2026-2031 (KILOTON)
  • TABLE 130 MIDDLE EAST & AFRICA: MEDICAL PLASTICS MARKET, BY TYPE, 2023-2025 (USD MILLION)
  • TABLE 131 MIDDLE EAST & AFRICA: MEDICAL PLASTICS MARKET, BY TYPE, 2026-2031 (USD MILLION)
  • TABLE 132 MIDDLE EAST & AFRICA: MEDICAL PLASTICS MARKET, BY TYPE, 2023-2025 (KILOTON)
  • TABLE 133 MIDDLE EAST & AFRICA: MEDICAL PLASTICS MARKET, BY TYPE, 2026-2031 (KILOTON)
  • TABLE 134 MIDDLE EAST & AFRICA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023-2025 (USD MILLION)
  • TABLE 135 MIDDLE EAST & AFRICA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 136 MIDDLE EAST & AFRICA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023-2025 (KILOTON)
  • TABLE 137 MIDDLE EAST & AFRICA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026-2031 (KILOTON)
  • TABLE 138 SAUDI ARABIA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023-2025 (USD MILLION)
  • TABLE 139 SAUDI ARABIA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 140 SAUDI ARABIA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023-2025 (KILOTON)
  • TABLE 141 SAUDI ARABIA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026-2031 (KILOTON)
  • TABLE 142 UAE: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023-2025 (USD MILLION)
  • TABLE 143 UAE: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 144 UAE: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023-2025 (KILOTON)
  • TABLE 145 UAE: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026-2031 (KILOTON)
  • TABLE 146 REST OF GCC: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023-2025 (USD MILLION)
  • TABLE 147 REST OF GCC: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 148 REST OF GCC: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023-2025 (KILOTON)
  • TABLE 149 REST OF GCC: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026-2031 (KILOTON)
  • TABLE 150 SOUTH AFRICA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023-2025 (USD MILLION)
  • TABLE 151 SOUTH AFRICA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 152 SOUTH AFRICA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023-2025 (KILOTON)
  • TABLE 153 SOUTH AFRICA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026-2031 (KILOTON)
  • TABLE 154 REST OF MIDDLE EAST & AFRICA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023-2025 (USD MILLION)
  • TABLE 155 REST OF MIDDLE EAST & AFRICA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 156 REST OF MIDDLE EAST & AFRICA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023-2025 (KILOTON)
  • TABLE 157 REST OF MIDDLE EAST & AFRICA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026-2031 (KILOTON)
  • TABLE 158 SOUTH AMERICA: MEDICAL PLASTICS MARKET, BY COUNTRY, 2023-2025 (USD MILLION)
  • TABLE 159 SOUTH AMERICA: MEDICAL PLASTICS MARKET, BY COUNTRY, 2026-2031 (USD MILLION)
  • TABLE 160 SOUTH AMERICA: MEDICAL PLASTICS MARKET, BY COUNTRY, 2023-2025 (KILOTON)
  • TABLE 161 SOUTH AMERICA: MEDICAL PLASTICS MARKET, BY COUNTRY, 2026-2031 (KILOTON)
  • TABLE 162 SOUTH AMERICA: MEDICAL PLASTICS MARKET, BY TYPE, 2023-2025 (USD MILLION)
  • TABLE 163 SOUTH AMERICA: MEDICAL PLASTICS MARKET, BY TYPE, 2026-2031 (USD MILLION)
  • TABLE 164 SOUTH AMERICA: MEDICAL PLASTICS MARKET, BY TYPE, 2023-2025 (KILOTON)
  • TABLE 165 SOUTH AMERICA: MEDICAL PLASTICS MARKET, BY TYPE, 2026-2031 (KILOTON)
  • TABLE 166 SOUTH AMERICA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023-2025 (USD MILLION)
  • TABLE 167 SOUTH AMERICA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 168 SOUTH AMERICA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023-2025 (KILOTON)
  • TABLE 169 SOUTH AMERICA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026-2031 (KILOTON)
  • TABLE 170 BRAZIL: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023-2025 (USD MILLION)
  • TABLE 171 BRAZIL: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 172 BRAZIL: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023-2025 (KILOTON)
  • TABLE 173 BRAZIL: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026-2031 (KILOTON)
  • TABLE 174 ARGENTINA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023-2025 (USD MILLION)
  • TABLE 175 ARGENTINA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 176 ARGENTINA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023-2025 (KILOTON)
  • TABLE 177 ARGENTINA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026-2031 (KILOTON)
  • TABLE 178 REST OF SOUTH AMERICA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023-2025 (USD MILLION)
  • TABLE 179 REST OF SOUTH AMERICA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 180 REST OF SOUTH AMERICA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023-2025 (KILOTON)
  • TABLE 181 REST OF SOUTH AMERICA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026-2031 (KILOTON)
  • TABLE 182 KEY STRATEGIES ADOPTED BY MAJOR PLAYERS IN MEDICAL PLASTICS MARKET, JANUARY 2021-JUNE 2026
  • TABLE 183 MEDICAL PLASTICS MARKET: DEGREE OF COMPETITION, 2025
  • TABLE 184 MEDICAL PLASTICS MARKET: REGION FOOTPRINT
  • TABLE 185 MEDICAL PLASTICS MARKET: TYPE FOOTPRINT
  • TABLE 186 MEDICAL PLASTICS MARKET: APPLICATION FOOTPRINT
  • TABLE 187 MEDICAL PLASTICS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 188 MEDICAL PLASTICS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • TABLE 189 MEDICAL PLASTICS MARKET: PRODUCT LAUNCHES, JANUARY 2020-JUNE 2026
  • TABLE 190 MEDICAL PLASTICS MARKET: DEALS, JANUARY 2020-JUNE 2026
  • TABLE 191 MEDICAL PLASTICS MARKET: EXPANSIONS, JANUARY 2020-JUNE 2026
  • TABLE 192 BASF: COMPANY OVERVIEW
  • TABLE 193 BASF: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 194 BASF: PRODUCT LAUNCHES, JANUARY 2021-JUNE 2026
  • TABLE 195 BASF: EXPANSIONS, JANUARY 2021-JUNE 2026
  • TABLE 196 CELANESE CORPORATION: COMPANY OVERVIEW
  • TABLE 197 CELANESE CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 198 CELANESE CORPORATION: DEALS, JANUARY 2021-JUNE 2026
  • TABLE 199 SABIC: COMPANY OVERVIEW
  • TABLE 200 SABIC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 201 SABIC: PRODUCT LAUNCHES, JANUARY 2021-JUNE 2026
  • TABLE 202 SABIC: DEALS, JANUARY 2021-JUNE 2026
  • TABLE 203 COVESTRO AG: COMPANY OVERVIEW
  • TABLE 204 COVESTRO AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 205 COVESTRO AG: PRODUCT LAUNCHES, JANUARY 2021-JUNE 2026
  • TABLE 206 SYENSQO: COMPANY OVERVIEW
  • TABLE 207 SYENSQO: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 208 SYENSQO: PRODUCT LAUNCHES, JANUARY 2021-JUNE 2026
  • TABLE 209 SYENSQO: DEALS, JANUARY 2021-JUNE 2026
  • TABLE 210 EVONIK INDUSTRIES: COMPANY OVERVIEW
  • TABLE 211 EVONIK INDUSTRIES: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 212 EVONIK INDUSTRIES: PRODUCT LAUNCHES, JANUARY 2021-JUNE 2026
  • TABLE 213 EVONIK INDUSTRIES: EXPANSIONS, JANUARY 2021-JUNE 2026
  • TABLE 214 ARKEMA: COMPANY OVERVIEW
  • TABLE 215 ARKEMA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 216 ARKEMA: PRODUCT LAUNCHES, JANUARY 2021-JUNE 2026
  • TABLE 217 ARKEMA: DEALS, JANUARY 2021-JUNE 2026
  • TABLE 218 LUBRIZOL: COMPANY OVERVIEW
  • TABLE 219 LUBRIZOL: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 220 LUBRIZOL: PRODUCT LAUNCHES, JANUARY 2021-JUNE 2026
  • TABLE 221 LUBRIZOL: DEALS, JANUARY 2021-JUNE 2026
  • TABLE 222 LUBRIZOL: EXPANSIONS, JANUARY 2021-JUNE 2026
  • TABLE 223 ENSINGER: COMPANY OVERVIEW
  • TABLE 224 ENSINGER: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 225 DOW: COMPANY OVERVIEW
  • TABLE 226 DOW: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 227 DOW: DEALS, JANUARY 2021-JUNE 2026
  • TABLE 228 TRINSEO: COMPANY OVERVIEW
  • TABLE 229 BIOMERICS: COMPANY OVERVIEW
  • TABLE 230 ENVALIOR: COMPANY OVERVIEW
  • TABLE 231 EASTMAN CHEMICAL COMPANY: COMPANY OVERVIEW
  • TABLE 232 INVIBIO LTD.: COMPANY OVERVIEW
  • TABLE 233 LYONDELLBASELL INDUSTRIES HOLDINGS B.V.: COMPANY OVERVIEW
  • TABLE 234 MITSUBISHI CHEMICAL GROUP: COMPANY OVERVIEW
  • TABLE 235 AVIENT CORPORATION: COMPANY OVERVIEW
  • TABLE 236 ROCHLING SE & CO. KG: COMPANY OVERVIEW
  • TABLE 237 RTP COMPANY: COMPANY OVERVIEW
  • TABLE 238 SAINT-GOBAIN: COMPANY OVERVIEW
  • TABLE 239 TEKNI-PLEX, INC.: COMPANY OVERVIEW
  • TABLE 240 TEKNOR APEX COMPANY: COMPANY OVERVIEW
  • TABLE 241 WACKER CHEMIE AG: COMPANY OVERVIEW
  • TABLE 242 GEON PERFORMANCE SOLUTIONS LLC: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 MEDICAL PLASTICS MARKET SEGMENTATION AND REGIONAL SCOPE
  • FIGURE 2 KEY INSIGHTS AND MARKET HIGHLIGHTS
  • FIGURE 3 MEDICAL PLASTICS MARKET, 2025-2031
  • FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN MEDICAL PLASTICS MARKET (2021-2025)
  • FIGURE 5 DISRUPTIVE TRENDS IMPACTING GROWTH OF MEDICAL PLASTICS MARKET
  • FIGURE 6 HIGH-GROWTH SEGMENTS AND EMERGING FRONTIERS IN MEDICAL PLASTICS MARKET, 2026-2031
  • FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 8 HIGH DEMAND FOR MEDICAL DISPOSABLES TO CREATE LUCRATIVE OPPORTUNITIES FOR MARKET PLAYERS
  • FIGURE 9 CHINA ACCOUNTED FOR LARGEST MARKET SHARE IN 2025
  • FIGURE 10 PP SEGMENT ACCOUNTED FOR LARGEST SHARE OF MEDICAL PLASTICS MARKET IN 2025
  • FIGURE 11 INDIA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 12 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN MEDICAL PLASTICS MARKET
  • FIGURE 13 MEDICAL PLASTICS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 14 MEDICAL PLASTICS MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 15 MEDICAL PLASTICS MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 16 AVERAGE SELLING PRICE TREND OF MEDICAL PLASTICS, BY REGION (2023-2025)
  • FIGURE 17 IMPORT DATA FOR HS CODE 3926-COMPLIANT PRODUCTS, BY KEY COUNTRIES, 2021-2025
  • FIGURE 18 EXPORT DATA RELATED TO HS CODE 3936-COMPLIANT PRODUCTS, BY KEY COUNTRIES, 2021-2025
  • FIGURE 19 TRENDS/DISRUPTIONS INFLUENCING MEDICAL PLASTICS MARKET GROWTH
  • FIGURE 20 INVESTMENT AND FUNDING SCENARIO, 2020-2025
  • FIGURE 21 LIST OF MAJOR PATENTS FOR MEDICAL PLASTICS, 2016-2025
  • FIGURE 22 PATENT ANALYSIS, BY LEGAL STATUS
  • FIGURE 23 TOP JURISDICTION, BY DOCUMENT
  • FIGURE 24 MEDICAL PLASTICS MARKET: DECISION-MAKING FACTORS
  • FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY APPLICATIONS
  • FIGURE 26 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
  • FIGURE 27 ADOPTION BARRIERS & INTERNAL CHALLENGES
  • FIGURE 28 ENGINEERING AND HIGH PERFORMANCE PLASTICS TO ACCOUNT FOR LARGEST MARKET SHARE IN 2026
  • FIGURE 29 MEDICAL DISPOSABLES TO BE LARGEST APPLICATION IN MEDICAL PLASTICS MARKET DURING FORECAST PERIOD
  • FIGURE 30 INDIA TO REGISTER HIGHEST CAGR IN MEDICAL PLASTICS MARKET DURING FORECAST PERIOD
  • FIGURE 31 NORTH AMERICA: MEDICAL PLASTICS MARKET SNAPSHOT
  • FIGURE 32 ASIA PACIFIC: MEDICAL PLASTICS MARKET SNAPSHOT
  • FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS IN MEDICAL PLASTICS MARKET, 2021-2025
  • FIGURE 34 MEDICAL PLASTICS MARKET SHARE ANALYSIS, 2025
  • FIGURE 35 MEDICAL PLASTICS MARKET: PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 36 MEDICAL PLASTICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
  • FIGURE 37 MEDICAL PLASTICS MARKET: COMPANY FOOTPRINT
  • FIGURE 38 MEDICAL PLASTICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
  • FIGURE 39 EV/EBITDA OF KEY MANUFACTURERS IN MEDICAL PLASTICS MARKET
  • FIGURE 40 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY MANUFACTURERS IN MEDICAL PLASTICS MARKET
  • FIGURE 41 ENTERPRISE VALUATION OF KEY PLAYERS IN MEDICAL PLASTICS MARKET (2025)
  • FIGURE 42 BASF: COMPANY SNAPSHOT
  • FIGURE 43 CELANESE CORPORATION: COMPANY SNAPSHOT
  • FIGURE 44 SABIC: COMPANY SNAPSHOT
  • FIGURE 45 COVESTRO AG: COMPANY SNAPSHOT
  • FIGURE 46 SYENSQO: COMPANY SNAPSHOT
  • FIGURE 47 EVONIK INDUSTRIES: COMPANY SNAPSHOT
  • FIGURE 48 ARKEMA: COMPANY SNAPSHOT
  • FIGURE 49 DOW: COMPANY SNAPSHOT
  • FIGURE 50 MEDICAL PLASTICS MARKET: RESEARCH DESIGN
  • FIGURE 51 BREAKDOWN OF INTERVIEWS WITH EXPERTS
  • FIGURE 52 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  • FIGURE 53 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
  • FIGURE 54 MEDICAL PLASTICS MARKET: APPROACH 1
  • FIGURE 55 MEDICAL PLASTICS MARKET: APPROACH 2
  • FIGURE 56 MEDICAL PLASTICS MARKET: DATA TRIANGULATION